As for new targets, the glucose-dependent insulinotropic polypeptide receptor (GIPR), an interesting target for the imaging of neuroendocrine tumours (NET), was presented by Gourni et al. [10]. This evidence concerns the gene GIPR and neuroendocrine neoplasm.